Subscribe
shutterstock_1086968018_jarretera-1
jarretera / Shutterstock.com
13 March 2019Americas

National Cancer Institute’s director named as acting FDA chief

The Trump administration has named Ned Sharpless, director of the National Cancer Institute (NCI), as the Food and Drug Administration's (FDA) acting commissioner.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
FDA chief Gottlieb resigns after nearly two years
6 March 2019   Scott Gottlieb, commissioner of the US Food and Drug Administration, resigned from his post yesterday, March 5, with plans to step down in the next month.
Americas
Former FDA head takes place on Pfizer board
28 June 2019   Pfizer has appointed former US Food and Drug Administration commissioner Scott Gottlieb to its board.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Americas
Former FDA head takes place on Pfizer board
28 June 2019   Pfizer has appointed former US Food and Drug Administration commissioner Scott Gottlieb to its board.
Americas
FDA chief Gottlieb resigns after nearly two years
6 March 2019   Scott Gottlieb, commissioner of the US Food and Drug Administration, resigned from his post yesterday, March 5, with plans to step down in the next month.

More on this story

Americas
Former FDA head takes place on Pfizer board
28 June 2019   Pfizer has appointed former US Food and Drug Administration commissioner Scott Gottlieb to its board.
Americas
FDA chief Gottlieb resigns after nearly two years
6 March 2019   Scott Gottlieb, commissioner of the US Food and Drug Administration, resigned from his post yesterday, March 5, with plans to step down in the next month.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York